Effect of Pre-exposure Use of Amantadine on COVID-19 Infection: A Hospital-Based Cohort Study in Patients With Parkinson's Disease or Multiple Sclerosis

Effect of Pre-exposure Use of Amantadine on COVID-19 Infection: A Hospital-Based Cohort Study in Patients With Parkinson's Disease or Multiple Sclerosis

Background: Amantadine has been proposed to inhibit E-channel conductance in reconstituted lipid bilayers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We aimed to study whether patients on amantadine have altered risks of contracting COVID-19 infection.Methods: We conducted a hos...

Full description

Bibliographic Details
Main Authors: Walaa A. Kamel, Mohmed I. Kamel, Almunther Alhasawi, Sameh Elmasry, Fajer AlHamdan, Jasem Y. Al-Hashel
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Neurology
Subjects:
Amantadine
pre-exposure
COVID-19
infection
multiple sclerosis
Parkinson's disease
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.704186/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.704186/full

Similar Items